Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Crohn's disease
Pharma
J&J's Tremfya picks up key FDA nod in Crohn's disease
With another IBD approval in the bag for Tremfya, Johnson & Johnson is making good on the succession plan for its autoimmune blockbuster Stelara.
Fraiser Kansteiner
Mar 20, 2025 7:56pm
Lilly's Omvoh bests J&J's Stelara in Crohn's study
Oct 14, 2024 12:15pm
Subcutaneous version of J&J's Tremfya excels in Crohn's trial
Jun 20, 2024 11:12am
UPDATED: J&J readies Tremfya for IBD showdown with AbbVie, Lilly
May 21, 2024 9:49am
Lilly pads case for mirikizumab in its next potential indication
May 21, 2024 9:20am
Celltrion signs 'The Traitors' star for bowel disease campaign
May 20, 2024 10:10am
